4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-251395
Chief Scientific Officer sold 6,000 shares at $19.87 ($119,220)
- Chief Scientific Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Townson Sharon · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,000 | $6.14 | $36,840 | 73,845 | D |
| 2026-05-29 | Sale : show line 2 in the form 10b5-1 | −6,000 | $19.87 | $119,220 | 67,845 | D |
| Open-market sales · 6,000 sh · avg $19.87 · $119,220 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-29 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −6,000 | 209,290 | D |
Loading xslF345X06/ownership.xml…